![](/img/cover-not-exists.png)
Where is the place of DPP-4 inhibitor in type 2 DM treatment? As mono or combine therapy?
Soetedjo, N.N.M.Volume:
7
Language:
english
Journal:
Obesity Research & Clinical Practice
DOI:
10.1016/j.orcp.2013.08.034
Date:
October, 2013
File:
PDF, 54 KB
english, 2013